Sylentis
Sylentis is an European biotechnological company founded in 2006. Sylentis focuses on researching new therapeutic approaches based on gene silencing. Our company is specialised in developing ophtalmologic therapies via interference RNA, a powerful tool for rational drug design. Most advanced product of the company are treatments for glaucoma and dry eye syndrome. Sylentis is a wholly owned member of PharmaMar
7-day free trial · no credit card
Verified contacts
48
available on Kipplo
LinkedIn employees
54
51 to 200 range
Open roles
—
no listings
Distinct roles
33
indexed titles
Tech stack
0
tools in use
Monthly traffic
122
organic / mo
Sign up free to see all 48 verified contacts at Sylentis
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
48 contacts with verified email or phone · masked until revealed.
Showing 1 of 48 verified contacts
Top roles at Sylentis
33 distinct titles indexed · top 10 shown.
- 4técnico de laboratorio
- 2jefe adjunto de producción
- 2quality control technician
- 2r & d scientist
- 2responsable de control de calidad
- 2técnico de garantia de calidad
- 2técnico de producción
- 2técnico superior de laboratorio
- 1administrador de sistemas
- 1business development manager
- +23more titles
Sign up to unlock all 48 contacts at Sylentis
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 48 verified contacts at Sylentis
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.